ArticleNeurologia medico-chirurgica2017

Immunotherapy of Nivolumab with Dendritic Cell Vaccination Is Effective against Intractable Recurrent Primary Central Nervous System Lymphoma: A Case Report.

Motomasa Furuse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.